Circulating messenger RNA of α-fetoprotein: A possible risk factor of recurrence after resection of hepatocellular carcinoma

Archives of Surgery

Volumn 139, Issue 10, 2004, Pages 1055-1060

  Jeng, Kuo Shyang ^c   Sheen, I Shyan ^b   Tsai, Yi Chun ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c Chang Gung Memorial Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RATING SCALE; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SURVIVAL; TUMOR CELL; TUMOR RECURRENCE;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RISK FACTORS; RNA, MESSENGER;

EID: 5444231788     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.10.1055     Document Type: Article

References (31)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-285.
2. Lin TY, Lee CS, Chen KM, Chen CC. Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience. Br J Surg. 1987;74:839-842.
3. Chen MF, Hwang TL, Jeng LB, Wang CS, Jan YY, Chen SC. Postoperative recurrence of hepatocellular carcinoma: 205 consecutive patients who underwent hepatic resection in 15 years. Arch Surg. 1994;129:738-742.
4. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105:488-494.
5. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 1999;19:311-322.
6. Cave H, van der Werff ten Bosch J, Suciu S, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. N Engl J Med. 1998;339:591-598.
7. Yamanaka N, Okamoto E, Toyosaka A, et al. Prognostic factors after hepatectomy for hepatocellular carcinoma: a univariate and multivariate analysis. Cancer. 1990;65:1104-1110.
8. Giorgio E, Gian Luca G, Matteo R, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg. 2003;237:536-543.
9. Matsumura M, Niwa Y, Hikiba Y, et al. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha fetoprotein mRNA) in blood. Biochem Biophys Res Commun. 1995;207:813-818.
10. Komeda T, Fukuda Y, Sando T, et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer. 1995;75:2214-2219.
11. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer: classification of isolated tumor cells and micrometastasis. Cancer. 1999; 86:2668-2673.
12. Keene SA, Demeure MJ. The clinical significance of micrometastases and molecular metastases. Surgery. 2001;129:1-5.
13. Matsumura M, Niwa Y, Kato N, et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology. 1994;20:1418-1425.
14. Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology. 1997;25:564-568.
15. Matsumura M, Shiratori Y, Niwa Y, et al. Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma. J Hepatol. 1999;31:332-339.
16. Okuda N, Nakao A, Takeda S, et al. Clinical significance of alpha fetoprotein mRNA during perioperative period in HCC. Hepatogastroenterology. 1999;46:381-386.
17. Kienle P, Weitz J, Klaes R, et al. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma. Arch Surg. 2000;135:213-218.
18. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. Alpha-fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology. 2002;35:853-860.
19. Witzigmann H, Geibler F, Benedix F, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery. 2002;131:34-43.
20. Oppenheim A, Karsai A, Treisman R, et al. Beta-thalassemia: analysis of mRNA precursors of a mutant human globin gene with defective splicing using peripheral blood nucleated red blood cells. Hemoglobin. 1986;10:573-586.
21. Goldblatt SA, Nadel EM. Cancer cells in the circulating blood: a critical review. Acta Cytol. 1965;9:6-20.
22. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastasis following tumor implantation. Cancer Res. 1974;34:997-1004.
23. Glaves D. Correlation between circulation cancer cells and incidence of metastasis. Br J Cancer. 1983;48:665-667.
24. Lemoine A, Le Bricon T, Salvucci M, et al. Prospective evaluation of circulating hepatocyles by alpha fetoprotein mRNA in humans during liver surgery. Ann Surg. 1997;226:43-50.
25. Miyamoto A, Fujiwara Y, Sakon M, et al. Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma. Dig Dis Sci. 2000;45:1376-1382.
26. Ishikawa T, Kashiwagi H, Iwakami Y, et al. Expression of alpha fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction. Jpn J Clin Oncol. 1998;28:723-728.
27. Wong IHN, Lau WY, Leung T, Johnson PJ. Quantitative comparison of alpha fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett. 2000;156:141-149.
28. Wong INH, Lau WY, Leung T, Yeo W, Johnson PJ. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res. 1999;5:4021-4027.
29. Niwa Y, Matsumura M, Shiratori Y, et al. Quantitation of alphafetoprotein and albumin messenger RNAs in human hepatocellular carcinoma. Hepatology. 1996; 23:1384-1392.
30. Evans RA. The "seed and soil" hypothesis and the decline of radical surgery: a surgeon's opinion. Tex Med. 1990;86:85-89.
31. Jeng KS, Sheen IS, Chen BF, Wu JY. Is the p53gene mutation of prognostic value in hepatocellular carcinoma after resection? Arch Surg. 2000;135:1329-1333.